SCHEMBL18974709

SCHEMBL18974709

C=C1C(=O)c2ccccc2N1Cc1ccc(F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.57
ALDH3A1 P30838 5/20 0.56
CES1 P23141 4/20 0.55
ACHE P22303 2/20 0.55
ALDH1A1 P00352 4/20 0.54
CHRM1 P11229 3/20 0.54
ALDH2 P05091 1/20 0.54
BCHE P06276 2/20 0.54
CES2 O00748 1/20 0.54
CHRM5 P08912 2/20 0.52
CHRM3 P20309 1/20 0.52
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.52
UBE2N P61088 1/20 0.52
ATM Q13315 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TSHR P16473 2/20 0.49
CYP1A2 P05177 2/20 0.49
APAF1 O14727 1/20 0.49
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4597810 0.84 CES1 (0.77) CASP3ALDH3A1CES1ACHEALDH1A1
SCHEMBL30774308 0.84 CES1 (0.77) CASP3ALDH3A1CES1ACHEALDH1A1
SCHEMBL18974326 0.75 ALDH1A1 (0.50) ALDH3A1CES1ACHEALDH1A1CHRM1
SCHEMBL18974314 0.75 CHRM5 (0.55) ALDH3A1CES1ALDH1A1CHRM1ALDH2
SCHEMBL2644044 0.75 CASP3 (0.87) CASP3ALDH1A1LMNAHPGDUBE2N
SCHEMBL18288159 0.75 CES1 (0.90) CASP3ALDH3A1CES1ACHEALDH1A1
SCHEMBL13442861 0.73 CASP3 (1.00) CASP3ALDH3A1CES1ACHEALDH1A1
SCHEMBL13627894 0.72 LMNA (0.59) CASP3ALDH3A1CES1ACHEALDH1A1
SCHEMBL16798764 0.72 ALDH3A1 (1.00) CASP3ALDH3A1CES1ACHEALDH1A1
SCHEMBL9096595 0.72 ALDH3A1 (0.80) CASP3ALDH3A1CES1ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 WO disclosed